Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of January 18 - 24, 2021.

Dr Morgan begins by highlighting the FDA approval of the combination of nivolumab and cabozatinib as a first line treatment in advanced kidney cancer based on the results of Checkmate 9ER.

Alerts this week cover papers from JAMA, JTO, Lancet Oncology, Cell Patterns, JCO, Nature and Clinical Cancer Research covering disease areas including lung, breast, prostate and cervical.

You can watch Dr Morgan's previous roundup here.

Follow Dr Morgan on twitter: @OncoAlert

Follow ecancer on twitter: @ecancer